DK136884B - Fremgangsmåde til stabilisering af et topisk anvendeligt oftalmisk medikament, der indeholder oxotremorin eller dehydrooxotremorin. - Google Patents

Fremgangsmåde til stabilisering af et topisk anvendeligt oftalmisk medikament, der indeholder oxotremorin eller dehydrooxotremorin.

Info

Publication number
DK136884B
DK136884B DK144574AA DK144574A DK136884B DK 136884 B DK136884 B DK 136884B DK 144574A A DK144574A A DK 144574AA DK 144574 A DK144574 A DK 144574A DK 136884 B DK136884 B DK 136884B
Authority
DK
Denmark
Prior art keywords
dehydrooxotremorine
oxotremorine
stabilizing
drug containing
ophthalmic drug
Prior art date
Application number
DK144574AA
Other languages
Danish (da)
English (en)
Inventor
John Raymond Smythies
Vithal Jagannath Rajadhyaksha
Frank Jeng Dea
Original Assignee
Nelson Res & Dev Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00341732A external-priority patent/US3824313A/en
Application filed by Nelson Res & Dev Company filed Critical Nelson Res & Dev Company
Publication of DK136884B publication Critical patent/DK136884B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
DK144574AA 1973-03-16 1974-03-15 Fremgangsmåde til stabilisering af et topisk anvendeligt oftalmisk medikament, der indeholder oxotremorin eller dehydrooxotremorin. DK136884B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00341732A US3824313A (en) 1973-03-16 1973-03-16 Topical opthalmic composition and methods of use
US44568574A 1974-02-25 1974-02-25

Publications (1)

Publication Number Publication Date
DK136884B true DK136884B (da) 1977-12-12

Family

ID=26992634

Family Applications (1)

Application Number Title Priority Date Filing Date
DK144574AA DK136884B (da) 1973-03-16 1974-03-15 Fremgangsmåde til stabilisering af et topisk anvendeligt oftalmisk medikament, der indeholder oxotremorin eller dehydrooxotremorin.

Country Status (7)

Country Link
JP (1) JPS5833202B2 (enrdf_load_stackoverflow)
CA (1) CA1024070A (enrdf_load_stackoverflow)
DE (1) DE2411019C2 (enrdf_load_stackoverflow)
DK (1) DK136884B (enrdf_load_stackoverflow)
ES (1) ES424362A1 (enrdf_load_stackoverflow)
FR (1) FR2221140B1 (enrdf_load_stackoverflow)
GB (1) GB1459264A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012041816A1 (en) 2010-09-30 2012-04-05 Solvay Sa Derivative of epichlorohydrin of natural origin
WO2020072971A1 (en) * 2018-10-06 2020-04-09 Biotheravision Llc Ophthalmic preparations of muscarinic agonist and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE300422B (enrdf_load_stackoverflow) * 1964-07-03 1968-04-29 Astra Ab

Also Published As

Publication number Publication date
CA1024070A (en) 1978-01-10
FR2221140B1 (enrdf_load_stackoverflow) 1977-07-01
ES424362A1 (es) 1976-10-16
GB1459264A (en) 1976-12-22
JPS5833202B2 (ja) 1983-07-18
AU6679074A (en) 1975-09-18
JPS5035320A (enrdf_load_stackoverflow) 1975-04-04
DE2411019A1 (de) 1974-09-26
FR2221140A1 (enrdf_load_stackoverflow) 1974-10-11
DE2411019C2 (de) 1986-11-20

Similar Documents

Publication Publication Date Title
DK140484B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK129291B (da) Fremgangsmåde til fremstilling af et kimfattigt, flydedygtigt pancreatinpræparat.
DK144094C (da) Analogifremgangsmaade til fremstilling af n-substituerede 3-hydroxy-8-oxamorphinaner eller syreadditionssalte deraf
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
NO141655C (no) Konsentrert, flytende saapeopploesning
DK135268B (da) Fremgangsmåde til fremstilling af et ophthalmisk insulinpræparat.
DK138321B (da) Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater.
DK135676B (da) Fremgangsmåde til fremstilling af flydende svovldioxid.
DK135768B (da) Fremgangsmåde til fremstilling af 1-alkyl-3,5-diphenylpyrazoler.
DK143445C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive substituerede 1,1-diphenyl-3-amino-propanol-forbindelser
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
NL7410254A (nl) Carbaminezuurderivaten.
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
DK134279B (da) Analogifremgangsmåde til fremstilling af cycloalkylphenoxycarboxylsyrederivater.
DK136884B (da) Fremgangsmåde til stabilisering af et topisk anvendeligt oftalmisk medikament, der indeholder oxotremorin eller dehydrooxotremorin.
DK134485B (da) Analogifremgangsmåde til fremstilling af thiocarbaminsyrederivater.
DK135723B (da) Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner.
DK132328B (da) Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on.
DK139140B (da) Fremgangsmåde til fremstilling af dilactonforbindelser.
DK136602B (da) Fremgangsmåde til fremstilling af farvet mangan-ethylen-bis-dithiocarbamat (maneb).
DK137449B (da) Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid.
DK135943B (da) Fremgangsmåde til fremstilling af propanolaminderivater.
DK140259B (da) Analogifremgangsmåde til fremstilling af 1-(L-(-)-omega-amino-alfa-hydroxyalkanoyl)-kanamyciner eller syreadditionssalte deraf.
DK136619B (da) Fremgangsmåde til fremstilling af dihydrokanadensolid.
DK137928B (da) Fremgangsmåde til fremstilling af 5alfa-hydroxygona-9,11-diener.